{
  "took": 16,
  "timed_out": false,
  "_shards": { "total": 1, "successful": 1, "skipped": 0, "failed": 0 },
  "hits": {
    "total": 489,
    "max_score": 22.029736,
    "hits": [
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254392",
        "_score": 22.029736,
        "_source": {
          "altsourceshort": ["CKS"],
          "metadescription": "Prostate cancer is amalignant tumour of the prostate. Almost all cancers of the prostate (95%) are adenocarcinomas.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254392,
          "title": "Prostate cancer",
          "url": "https://cks.nice.org.uk/topics/prostate-cancer/",
          "source_name": "CKS",
          "landing_url": "https://cks.nice.org.uk/topics/prostate-cancer/"
        },
        "highlight": {
          "title": ["Prostate <b>cancer</b>"],
          "content": [
            "Prostate <mark>cancer</mark> is a malignant tumour of the prostate. Almost all <mark>cancers</mark> of the prostate (95%) are adenocarcinomas. Prostate <mark>cancer</mark> is multifocal — the",
            "differ greatly in growth rate and ability to metastasize. Most prostate <mark>cancers</mark> are indolent and grow slowly — a minority are aggressive and invade local",
            " Localized prostate <mark>cancer</mark> usually develops in the outer zone of the prostate, where it seldom causes symptoms. Locally advanced prostate <mark>cancer</mark> extends beyond",
            "Metastatic prostate <mark>cancer</mark> most frequently affects the bones, where it causes pain and fragility fractures.  About 26% of all new cases of <mark>cancer</mark> in men are prostate",
            "prostate <mark>cancer</mark> — it is the most common type of <mark>cancer</mark> in men. Prostate <mark>cancer</mark> is the second most common cause of <mark>cancer</mark> death in males in the UK (after"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254361",
        "_score": 21.975456,
        "_source": {
          "altsourceshort": ["CKS"],
          "metadescription": "The lifetime risk of a woman being diagnosed with ovarian cancer is 1 in 52.The risk of ovarian cancer is increased by:Increasing age.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254361,
          "title": "Ovarian cancer",
          "url": "https://cks.nice.org.uk/topics/ovarian-cancer/",
          "source_name": "CKS",
          "landing_url": "https://cks.nice.org.uk/topics/ovarian-cancer/"
        },
        "highlight": {
          "title": ["Ovarian <b>cancer</b>"],
          "content": [
            "Ovarian <mark>cancer</mark> is <mark>cancer</mark> which arises from the ovary.Epithelial <mark>cancers</mark> account for approximately 90% of primary ovarian <mark>cancers</mark> and include serous (70–85%",
            "cell, and squamous tumours. Non-epithelial <mark>cancers</mark> account for approximately 10% of primary ovarian <mark>cancers</mark> and include germ cell tumours, ovarian carcinosarcoma",
            "the ovary, most notably from <mark>cancers</mark> of the endometrium, breast, gastrointestinal tract, and cervix (rare). Ovarian <mark>cancer</mark> may spread to intraperitoneal",
            "ovarian <mark>cancer</mark> is about 1 in 52. The risk of ovarian <mark>cancer</mark> is increased by factors such as increasing age, family history of ovarian or breast <mark>cancer</mark>, gene",
            "gene mutation, and endometriosis. The risk of ovarian <mark>cancer</mark> is reduced by factors such as an increasing number of pregnancies, breastfeeding, and the use"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2256193",
        "_score": 21.656155,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "diagnosis;diagnoses",
          "metadescription": "Localised prostate cancer is usually asymptomatic and&nbsp;localised advanced prostate cancer is also frequently asymptomatic.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2256193,
          "title": "Prostate cancer: What are the signs and symptoms of prostate cancer?",
          "url": "https://cks.nice.org.uk/topics/prostate-cancer/diagnosis/signs-symptoms/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/prostate-cancer/diagnosis/signs-symptoms/"
        },
        "highlight": {
          "title": [
            "Prostate <b>cancer</b>: What are the signs and symptoms of prostate <b>cancer</b>?"
          ],
          "content": [
            "signs and symptoms of prostate <mark>cancer</mark>? Localised prostate <mark>cancer</mark> is usually asymptomatic and localised advanced prostate <mark>cancer</mark> is also frequently asymptomatic",
            "the first symptoms of prostate <mark>cancer</mark>, as they frequently metastasize to the bones and cause pain.  Suspect prostate <mark>cancer</mark> in men who have: Any of the following",
            "in older men and early prostate <mark>cancer</mark> will not usually produce these symptoms. However, locally advanced prostate <mark>cancer</mark> may cause obstructive LUTS.  ",
            "that is hard and nodular on DRE  — normal DRE does not exclude prostate <mark>cancer.</mark> PSA  levels that are raised, or rising  (and urinary tract infection, or",
            "(NICE) guideline Suspected <mark>cancer</mark>: recognition and referral [NICE, 2015a ], the Public Health England (PHE) guidance Prostate <mark>cancer</mark> risk management programme"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2256192",
        "_score": 21.29243,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "diagnosis;diagnoses",
          "metadescription": "If the man has signs and symptoms &nbsp;which lead to a suspicion of prostate cancer:Discuss the benefits and harms of&nbsp;prostate-specific antigen (PSA) &nbsp;testing,...",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2256192,
          "title": "Prostate cancer: Overview of the diagnosis of prostate cancer",
          "url": "https://cks.nice.org.uk/topics/prostate-cancer/diagnosis/overview/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/prostate-cancer/diagnosis/overview/"
        },
        "highlight": {
          "title": [
            "Prostate <b>cancer</b>: Overview of the diagnosis of prostate <b>cancer</b>"
          ],
          "content": [
            "Overview of the diagnosis of prostate <mark>cancer</mark> If the man has signs and symptoms  which lead to a suspicion of prostate <mark>cancer</mark>:Discuss the benefits and harms ",
            "rectal examination  (DRE). Refer  urgently to a urological <mark>cancer</mark> specialist if prostate <mark>cancer</mark> is suspected — either because the prostate is hard and nodular",
            "recommendations are based on the Public Health England (PHE) guidance Prostate <mark>cancer</mark> risk management programme (PCRMP): benefits and risks of PSA testing  [PHE",
            "Suspected <mark>cancer</mark>: recognition and referral  [NICE, 2015a ], Lower urinary tract symptoms in men: management  [NICE, 2015c ], and Prostate <mark>cancer</mark>: diagnosis",
            "recommendations are based on the Public Health England (PHE) guidance Prostate <mark>cancer</mark> risk management programme (PCRMP): benefits and risks of PSA testing  [PHE"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2255992",
        "_score": 20.793955,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "diagnosis;diagnoses",
          "metadescription": "Suspect ovarian cancer and carry out tests : In any woman (particularly if over 50 years of age)&nbsp;if any of the following symptoms are persistent or frequent...",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2255992,
          "title": "Ovarian cancer: When should I suspect ovarian cancer?",
          "url": "https://cks.nice.org.uk/topics/ovarian-cancer/diagnosis/when-to-suspect-ovarian-cancer/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/ovarian-cancer/diagnosis/when-to-suspect-ovarian-cancer/"
        },
        "highlight": {
          "title": [
            "Ovarian <b>cancer</b>: When should I suspect ovarian <b>cancer</b>?"
          ],
          "content": [
            "When should I suspect ovarian <mark>cancer</mark>? Suspect ovarian <mark>cancer</mark> and carry out tests : In any woman (particularly if over 50 years of age) if any of the following",
            "bowel syndrome for more information. Consider the possibility of ovarian <mark>cancer</mark> and consider carrying out tests in any woman who reports any of the following",
            " Malaise or fatigue. Change in bowel habit. Other symptoms of ovarian <mark>cancer</mark> that may be present include: Abnormal or postmenopausal bleeding. Gastrointestinal",
            "recommendation Symptoms associated with ovarian <mark>cancer</mark> Recommendations on when to suspect ovarian <mark>cancer</mark> are based on evidence identified by the National",
            "the guideline Ovarian <mark>cancer</mark>: the recognition and initial management of ovarian <mark>cancer</mark>  [National Collaborating Centre for <mark>Cancer</mark>, 2011 ].A systematic review"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254156",
        "_score": 20.471235,
        "_source": {
          "altsourceshort": ["CKS"],
          "metadescription": "Types of cervical cancer include:Squamous cell carcinoma and Cervical adenocarcinoma",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254156,
          "title": "Cervical cancer and HPV",
          "url": "https://cks.nice.org.uk/topics/cervical-cancer-hpv/",
          "source_name": "CKS",
          "landing_url": "https://cks.nice.org.uk/topics/cervical-cancer-hpv/"
        },
        "highlight": {
          "title": ["Cervical <b>cancer</b> and HPV"],
          "content": [
            "Types of cervical <mark>cancer</mark> include:Squamous cell carcinoma â about 70â80% of cases of cervical <mark>cancer.</mark> Cervical adenocarcinoma â about 10% of cases",
            "cases of cervical <mark>cancer.</mark> Cervical <mark>cancer</mark> is caused by persistent infection (longer than 2 years) with high-risk human papillomavirus (hrHPV). The development",
            "cervical <mark>cancer</mark> is a continuous process: changes in the cervical epithelium progress, and in some women develop into invasive cervical <mark>cancer.</mark> Changes may",
            "cervical <mark>cancer</mark> is amenable to detection and control through the cervical screening programme. The two most important risk factors for cervical <mark>cancer</mark> are:Acquiring",
            "condom is used. Many women with cervical <mark>cancer</mark> will be asymptomatic. The possibility of cervical <mark>cancer</mark> should be considered in a woman who has any"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254743",
        "_score": 20.447775,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "managing;management",
          "metadescription": "Take a family history of breast cancer when: A person has concerns about their family history of breast cancer.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254743,
          "title": "Breast cancer - managing FH: Scenario: Breast cancer - managing family history",
          "url": "https://cks.nice.org.uk/topics/breast-cancer-managing-fh/management/breast-cancer-managing-fh/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/breast-cancer-managing-fh/management/breast-cancer-managing-fh/"
        },
        "highlight": {
          "title": [
            "Breast <b>cancer</b> - managing FH: Scenario: Breast <b>cancer</b> - managing family history"
          ],
          "content": [
            "Breast <mark>cancer</mark> - managing family history From age 16 years onwards. When and how should I take a family history? Take a family history of breast <mark>cancer</mark> when:",
            "when: A person has concerns about their family history of breast <mark>cancer.</mark> A person has breast symptoms. It is clinically relevant, for example:In women over",
            "nephew, half-sister, and half-brother). Ask about:All <mark>cancer</mark> diagnoses (including breast <mark>cancer</mark>). People in whom a faulty gene  (such as BRCA1, BRCA2,",
            "identified. Age at diagnosis. Presence of bilateral disease. Male breast <mark>cancer.</mark> Multiple cases in the family (particularly on one side). Jewish ancestry",
            "Other related early onset tumours, such as ovarian, pancreatic, and prostate <mark>cancer</mark>, sarcoma, glioma, and adrenal carcinoma. Basis for recommendation"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254745",
        "_score": 20.4081,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "managing;management",
          "metadescription": "The terms used in the National Institute for Health and Care Excellence (NICE) guideline Suspected cancer: recognition and referral are as follows:Immediate: an...",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254745,
          "title": "Breast cancer - recognition and referral: Scenario: Referral for breast cancer",
          "url": "https://cks.nice.org.uk/topics/breast-cancer-recognition-referral/management/referral-for-breast-cancer/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/breast-cancer-recognition-referral/management/referral-for-breast-cancer/"
        },
        "highlight": {
          "title": [
            "Breast <b>cancer</b> - recognition and referral: Scenario: Referral for breast <b>cancer</b>"
          ],
          "content": [
            "Scenario: Referral for breast <mark>cancer</mark> From birth onwards. Referral timelines The terms used in the National Institute for Health and Care Excellence (NICE)",
            "(NICE) guideline Suspected <mark>cancer</mark>: recognition and referral are as follows:Immediate: an acute admission or referral occurring within a few hours, or even",
            "considered very urgent or urgent. Suspected <mark>cancer</mark> pathway referral: the patient is seen within the national target for <mark>cancer</mark> referrals (2 weeks at the time of",
            "of publication of the 2015 NICE guideline  Suspected <mark>cancer</mark>: recognition and referral ). Basis for recommendation This is a direct implementation of",
            "guideline  Suspected <mark>cancer</mark>: recognition and r eferral  [NICE, 2015 ]. When should I refer a person with suspected breast <mark>cancer</mark>? Refer people using"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254744",
        "_score": 20.378353,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "diagnosis;diagnoses",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254744,
          "title": "Breast cancer - recognition and referral: Symptoms suggestive of breast cancer",
          "url": "https://cks.nice.org.uk/topics/breast-cancer-recognition-referral/diagnosis/symptoms-suggestive-of-breast-cancer/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/breast-cancer-recognition-referral/diagnosis/symptoms-suggestive-of-breast-cancer/"
        },
        "highlight": {
          "title": [
            "Breast <b>cancer</b> - recognition and referral: Symptoms suggestive of breast <b>cancer</b>"
          ],
          "content": [
            "Symptoms suggestive of breast <mark>cancer</mark> Table 2. Symptoms suggestive of breast <mark>cancer.</mark> Symptom Possible <mark>cancer</mark> Referral recommendation Axillary lump (unexplained)",
            "(unexplained), age 30 years and over Breast <mark>cancer</mark> Consider a suspected <mark>cancer</mark> pathway referral (for an appointment within 2  weeks) Breast lump (unexplained)",
            "(unexplained) with or without pain, age 30 years and over Breast <mark>cancer</mark> Refer people using a suspected <mark>cancer</mark> pathway referral (for an appointment within 2  weeks)",
            "Breast lump (unexplained) with or without pain, under age 30 years Breast <mark>cancer</mark> Consider  non-urgent  referral Nipple changes of concern (in one nipple",
            "Breast <mark>cancer</mark> Refer people using a suspected <mark>cancer</mark> pathway referral (for an appointment within 2  weeks) Skin changes that suggest breast <mark>cancer</mark> Breast"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2255994",
        "_score": 20.289017,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "managing;management",
          "metadescription": "Carry out an abdominal and pelvic examination.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2255994,
          "title": "Ovarian cancer: Scenario: Managing a woman with suspected ovarian cancer",
          "url": "https://cks.nice.org.uk/topics/ovarian-cancer/management/managing-a-woman-with-suspected-ovarian-cancer/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/ovarian-cancer/management/managing-a-woman-with-suspected-ovarian-cancer/"
        },
        "highlight": {
          "title": [
            "Ovarian <b>cancer</b>: Scenario: Managing a woman with suspected ovarian <b>cancer</b>"
          ],
          "content": [
            "woman with suspected ovarian <mark>cancer</mark> From age 18 years onwards (Female). How should I manage a woman with suspected ovarian <mark>cancer</mark>? Carry out an abdominal and",
            "scan of the abdomen and pelvis. If the ultrasound is suggestive of ovarian <mark>cancer</mark>, refer the woman urgently to gynaecology (to be seen within 2 weeks) for",
            "(NICE) guideline Ovarian <mark>cancer</mark>: the recognition and initial management of ovarian <mark>cancer</mark>  [National Collaborating Centre for <mark>Cancer</mark>, 2011 ]. Abdominal and",
            "from symptomatic women in primary care, where the prevalence of ovarian <mark>cancer</mark> is lower. However, sensitivity analysis showed that changing the prevalence",
            "in the detection of ovarian <mark>cancer</mark> combined Doppler and morphometric ultrasound had [National Collaborating Centre for <mark>Cancer</mark>, 2011 ]:A sensitivity that"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254137",
        "_score": 20.044516,
        "_source": {
          "altsourceshort": ["CKS"],
          "metadescription": "A family history of breast cancer is one of the strongest risk factors for developing breast cancer, increasing with the number of affected relatives.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254137,
          "title": "Breast cancer - managing FH",
          "url": "https://cks.nice.org.uk/topics/breast-cancer-managing-fh/",
          "source_name": "CKS",
          "landing_url": "https://cks.nice.org.uk/topics/breast-cancer-managing-fh/"
        },
        "highlight": {
          "title": ["Breast <b>cancer</b> - managing FH"],
          "content": [
            "A family history of breast <mark>cancer</mark> is a strong risk factor for developing the disease. The risk increases with the number of relatives affected and the",
            "age of diagnosis the greater the risk), and is modified by other breast <mark>cancer</mark> risk factors, including age at menopause, parity, oral contraception, hormone",
            "therapy (HRT), and breastfeeding.  People without a personal history of breast <mark>cancer</mark> can be managed in primary care if they have only one first-degree relative",
            "with breast <mark>cancer</mark> when over 40 years of age, provided that none of the following are present in the family history:Bilateral breast <mark>cancer.</mark> Male breast",
            "breast <mark>cancer.</mark> Ovarian <mark>cancer.</mark> Jewish ancestry. Sarcoma in a relative younger than 45 years of age. Glioma or childhood adrenal cortical carcinomas. Complicated"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254846",
        "_score": 20.009296,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "diagnosis;diagnoses",
          "metadescription": "Consider the possibility of cervical cancer in a woman who has any of the following nonspecific symptoms:Intermenstrual bleeding.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254846,
          "title": "Cervical cancer and HPV: What clinical features could indicatecervical cancer?",
          "url": "https://cks.nice.org.uk/topics/cervical-cancer-hpv/diagnosis/clinical-features/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/cervical-cancer-hpv/diagnosis/clinical-features/"
        },
        "highlight": {
          "title": [
            "Cervical <b>cancer</b> and HPV: What clinical features could indicatecervical <b>cancer</b>?"
          ],
          "content": [
            "What clinical features could indicate  cervical <mark>cancer</mark>? Many women with cervical <mark>cancer</mark> will be asymptomatic and are diagnosed through the NHS Cervical",
            "cervical <mark>cancer</mark> in a woman who has any of the following nonspecific symptoms:Intermenstrual bleeding. Postcoital bleeding (risk of cervical <mark>cancer</mark> increases",
            "discharge. Pelvic pain/dyspareunia. Rarely, women may present with advanced <mark>cancer</mark> with such symptoms as pelvic discomfort or pain, renal failure, leakage",
            "guideline Management of cervical <mark>cancer</mark>  [SIGN, 2008 ], the British Medical Journal (BMJ) best practice guideline Cervical <mark>cancer</mark> [BMJ, 2016 ], expert opinion",
            "narrative reviews  Management of cervical <mark>cancer</mark>   [Blomfield, 2007 ], Diagnosis and management of cervical <mark>cancer</mark>  [Petignat and Roy, 2007 ], and a systematic"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2256198",
        "_score": 19.721905,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "managing;management",
          "metadescription": "Treatment for prostate cancer will be initiated and managed in secondary care.Follow up and monitoring, as well as&nbsp;early recognition and initial management...",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2256198,
          "title": "Prostate cancer: Scenario: Management",
          "url": "https://cks.nice.org.uk/topics/prostate-cancer/management/management/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/prostate-cancer/management/management/"
        },
        "highlight": {
          "title": ["Prostate <b>cancer</b>: Scenario: Management"],
          "content": [
            "Scenario: Management How is prostate <mark>cancer</mark> managed?  Treatment for prostate <mark>cancer</mark> will be initiated and managed in secondary care.Follow up and monitoring",
            "comorbidities, as well as the man's preferences.  Treatments options for prostate <mark>cancer</mark> include:  Watchful waiting  or active surveillance . Radical treatments",
            " What is the staging for prostate <mark>cancer</mark>? Table 1. Tumour Node Metastasis (TNM) classification of prostate <mark>cancer</mark> T – Primary tumour TX Primary tumour",
            "stratification for men with localized prostate <mark>cancer</mark> Table 1. Risk stratification for men with localized prostate <mark>cancer</mark> according to prostate-specific antigen",
            "includes locally advanced prostate <mark>cancer</mark> Source:  [NICE, 2014 ] What are the treatment options for localized prostate <mark>cancer</mark>? For men with:  Low risk — "
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254891",
        "_score": 19.464777,
        "_source": {
          "altsourceshort": ["CKS"],
          "keywords": "managing;management",
          "metadescription": "The terms used in the National Institute for Health and Care Excellence (NICE) guideline Suspected cancer: recognition and referral are as follows:Immediate: an...",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254891,
          "title": "Childhood cancers - recognition and referral: Scenario: Referral for childhood cancer",
          "url": "https://cks.nice.org.uk/topics/childhood-cancers-recognition-referral/management/referral-for-childhood-cancer/",
          "source_name": "CKS subsections",
          "landing_url": "https://cks.nice.org.uk/topics/childhood-cancers-recognition-referral/management/referral-for-childhood-cancer/"
        },
        "highlight": {
          "title": [
            "Childhood <b>cancers</b> - recognition and referral: Scenario: Referral for childhood <b>cancer</b>"
          ],
          "content": [
            "Scenario: Referral for childhood <mark>cancer</mark> From birth to 15 years. Referral timelines The terms used in the National Institute for Health and Care Excellence",
            "Excellence (NICE) guideline Suspected <mark>cancer</mark>: recognition and referral are as follows:Immediate: an acute admission or referral occurring within a few hours",
            "considered very urgent or urgent. Suspected <mark>cancer</mark> pathway referral: the patient is seen within the national target for <mark>cancer</mark> referrals (2 weeks at the time of",
            "of publication of the 2015 NICE guideline  Suspected <mark>cancer</mark>: recognition and referral ). Basis for recommendation This is a direct implementation of",
            "the National Institute for Health and Care Excellence guideline  Suspected <mark>cancer</mark>: recognition and r eferral  [NICE, 2015 ]. When should I refer a child"
          ]
        }
      },
      {
        "_index": "cks_2020_08_27",
        "_type": "document",
        "_id": "2254448",
        "_score": 19.449383,
        "_source": {
          "altsourceshort": ["CKS"],
          "metadescription": "Prostate cancer - over 41,000 new prostate cancers are diagnosed each year in the UK.",
          "boostvalue": 100,
          "feedertype": "pfeeders",
          "accredited": "False",
          "clusterid": -2254448,
          "title": "Urological cancers - recognition and referral",
          "url": "https://cks.nice.org.uk/topics/urological-cancers-recognition-referral/",
          "source_name": "CKS",
          "landing_url": "https://cks.nice.org.uk/topics/urological-cancers-recognition-referral/"
        },
        "highlight": {
          "title": ["Urological <b>cancers</b> - recognition and referral"],
          "content": [
            "Prostate <mark>cancer</mark> â over 41,000 new prostate <mark>cancers</mark> are diagnosed each year in the UK. A full time GP will usually diagnose one new person with prostate",
            "prostate <mark>cancer</mark> each year. The 5 year survival is approximately 80%. Refer men using a suspected <mark>cancer</mark> pathway referral (for an appointment within 2 weeks)",
            "weeks) for prostate <mark>cancer</mark> if their prostate feels malignant on digital rectal examination. Consider a prostate-specific antigen (PSA) test and digital rectal",
            "rectal examination to assess for prostate <mark>cancer</mark> in men with:Any lower urinary tract symptoms, such as nocturia, urinary frequency, hesitancy, urgency or",
            "haematuria. Refer men using a suspected <mark>cancer</mark> pathway referral (for an appointment within 2 weeks) for prostate <mark>cancer</mark> if their PSA levels are above the age-specific"
          ]
        }
      }
    ]
  },
  "aggregations": { "cardinality#unique_count": { "value": 489 } }
}
